The global bone growth stimulators market is on a dynamic growth trajectory, with an expected valuation of USD 2.1 billion in 2023. Projections indicate that the market will expand significantly, reaching approximately USD 5.4 billion by 2033. This growth reflects a substantial Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period.
Bone growth stimulators are increasingly recognized for their critical role in accelerating bone healing and promoting recovery in patients with fractures, spinal fusions, and other orthopedic conditions. The market’s robust growth is driven by rising incidences of bone-related disorders, advancements in technology, and an increasing focus on improving patient outcomes through innovative treatments.
A bone growth stimulator’s best advantage is that it accelerates the entire process of bone healing, resulting in faster recovery, shorter hospitalisation, higher cost-effectiveness, and fewer infections.
According to a recent study conducted by the International Osteoporosis Foundation, statistics revealed that more than200 a million people are suffering from osteoporosis. Worldwide, 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. These numbers are anticipated to increase at a fast pace in the assessment period, therefore, bolstering the demand for Bone Growth Stimulators worldwide.
Key Takeaways
- Because of an ageing population, rapid economic expansion in growing Asia-Pacific (APAC) countries, and an increase in the volume of spine surgeries, the Bone Growth Stimulators market in numerous Asia-Pacific countries is likely to grow rapidly over the forecast period.
- India is predicted to be the fastest-growing market in APAC, with a CAGR of 11.4%. Growth will be fueled by improvements in the country’s healthcare landscape.
- The US market for Bone Growth Stimulators is estimated to exceed US$ 2.2 billion by 2033.
- With a rise in medical tourism and a growing demand for less invasive procedures, the United Kingdom is expected to dominate the European Bone Growth Stimulators market in the next years. Sales are expected to account for 20.4% of the global market in 2022.
- The hospital segment is estimated to be valued more than US$ 743 million by 2028.
Competitive Landscape
The prominent players operating in the global Bone Growth Stimulators market are extensively investing in research and development activities in order to launch innovative and technologically advanced products that cater to an expanding customer base. In addition to that, dominant market players are heavily investing in mergers, acquisitions, collaborations, and partnerships to strengthen their distribution networks.
Some of the leading companies operating in the Bone Growth Stimulators Market are
- Zimmer Biomet Holdings Inc
- Bioventus LLC.
- DJO Global, Orthofix Holdings, Inc.
- Ossatec Benelux Ltd.
- IGEA
- Ito Co., Ltd.
More Insights into the Bone Growth Stimulators Market
The US is expected to dominate the North American region by garnering maximum sales in the global Bone Growth Stimulators market. The global market is anticipated to account for about 42.5% of the total market share in 2022. According to the CDC, around 1 out of every 4 US adults (23.7%, 58.5 million people) suffer from diagnosed arthritis. The incidence of arthritis and osteoarthritis is predicted to grow in the forthcoming years, which in turn will propel the demand for electrical Bone Growth Stimulators over the assessment period.
The UK is predicted to dominate the European Bone Growth Stimulators market in the forthcoming years, as it accounts for around 20.4% of the total market share in 2022. The growth is attributed to the growing preference for minimally invasive procedures and the rising popularity of medical tourism in the country.
A Full Report – Overview
Bone Growth Stimulators Markets by Category
Product Type:
- Non-Invasive Bone Growth Stimulators
- Capacitive Coupling (CC) Devices
- Pulsed Electromagnetic Field (PEMF) Devices
- Combined Magnetic Field (CMF) Devices
- Ultrasound Bone Growth Stimulators
- Invasive Bone Growth Stimulators
Application:
- Trauma Injury and Fractures
- Spinal Fusion
- Osteogenesis
End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
- Homecare settings
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
